Kuntz KM - Search Results

1

The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.

Jutkowitz E, Alarid-Escudero F, Kuntz KM, Jalal H. Jutkowitz E, et al. Among authors: kuntz km. Pharmacoeconomics. 2019 Jul;37(7):871-877. doi: 10.1007/s40273-019-00770-z. Pharmacoeconomics. 2019. PMID: 30761461 Free PMC article.

2

Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Jutkowitz E, Alarid-Escudero F, Choi HK, Kuntz KM, Jalal H. Jutkowitz E, et al. Among authors: kuntz km. Pharmacoeconomics. 2017 Oct;35(10):1073-1085. doi: 10.1007/s40273-017-0526-0. Pharmacoeconomics. 2017. PMID: 28631197

3

"Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier.

Alarid-Escudero F, Enns EA, Kuntz KM, Michaud TL, Jalal H. Alarid-Escudero F, et al. Among authors: kuntz km. Value Health. 2019 May;22(5):611-618. doi: 10.1016/j.jval.2019.02.008. Value Health. 2019. PMID: 31104743 Free PMC article.

4

Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio.

Alarid-Escudero F, Kuntz KM. Alarid-Escudero F, et al. Among authors: kuntz km. Pharmacoeconomics. 2020 Mar;38(3):285-296. doi: 10.1007/s40273-019-00859-5. Pharmacoeconomics. 2020. PMID: 31755032 Free PMC article.

5

CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis.

Alarid-Escudero F, Schrag D, Kuntz KM. Alarid-Escudero F, et al. Among authors: kuntz km. Value Health. 2022 Mar;25(3):409-418. doi: 10.1016/j.jval.2021.07.019. Epub 2021 Nov 2. Value Health. 2022. PMID: 35227453 Free PMC article.

6

Prioritizing Research Informing Antibiotic Prophylaxis Guidelines for Knee Arthroplasty Patients.

Kuntz KM, Alarid-Escudero F, Swiontkowski MF, Skaar DD. Kuntz KM, et al. JDR Clin Trans Res. 2022 Jul;7(3):298-306. doi: 10.1177/23800844211020272. Epub 2021 Jun 17. JDR Clin Trans Res. 2022. PMID: 34137291 Clinical Trial.

7

Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Jalal H, Goldhaber-Fiebert JD, Kuntz KM. Jalal H, et al. Among authors: kuntz km. Med Decis Making. 2015 Jul;35(5):584-95. doi: 10.1177/0272989X15578125. Epub 2015 Apr 3. Med Decis Making. 2015. PMID: 25840900 Free PMC article.

8

A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer.

Sathianathen NJ, Alarid-Escudero F, Kuntz KM, Lawrentschuk N, Bolton DM, Murphy DG, Kim SP, Konety BR. Sathianathen NJ, et al. Among authors: kuntz km. Eur Urol Oncol. 2019 Nov;2(6):649-655. doi: 10.1016/j.euo.2019.01.004. Epub 2019 Jan 30. Eur Urol Oncol. 2019. PMID: 31411985

9

Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis.

Sathianathen NJ, Kuntz KM, Alarid-Escudero F, Lawrentschuk NL, Bolton DM, Murphy DG, Weight CJ, Konety BR. Sathianathen NJ, et al. Among authors: kuntz km. J Urol. 2018 Dec;200(6):1215-1220. doi: 10.1016/j.juro.2018.06.016. Epub 2018 Jun 12. J Urol. 2018. PMID: 29906434

10

Nonidentifiability in Model Calibration and Implications for Medical Decision Making.

Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. Alarid-Escudero F, et al. Among authors: kuntz km. Med Decis Making. 2018 Oct;38(7):810-821. doi: 10.1177/0272989X18792283. Med Decis Making. 2018. PMID: 30248276 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters